| 1MHW | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | BP4, CSD, DAR, PEA | enzyme |
| ||||||||||||
| related structures | by homologous chain: 1CS8, 1ICF | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides., Chowdhury SF, Sivaraman J, Wang J, Devanathan G, Lachance P, Qi H, Menard R, Lefebvre J, Konishi Y, Cygler M, Sulea T, Purisima EO, J Med Chem 2002 Nov 21;45(24):5321-9. PMID:12431059 | ||||||||||||||
| Data retrieval |
![]() |
| View 1MHW in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |